Zhongyi Tong

Zhongyi Tong


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2023 in Frontiers in Endocrinology
Verified
Journal Article
Open access
HTHong Tan
Hong Tan
SWSisi Wang
Sisi Wang
FHFeifei Huang
Feifei Huang
ZTZhongyi Tong
Zhongyi Tong
Background: Breast and thyroid cancer are increasingly prevalent, but it remains unclear whether the observed associations are due to heightened medical surveillance or intrinsic etiological factors. Observational studies are vulnerable to residual confounding, reverse causality, and bias, which can compromise causal inference. In this study, we employed a two-sample Mendelian randomization (MR) analysis to establish a causal link between breast cancer and heightened thyroid cancer risk.Methods: We obtained the single nucleotide polymorphisms (SNPs) associated with breast cancer from a genome-wide association study (GWAS) conducted by the Breast Cancer Association Consortium (BCAC). The FinnGen consortium’s latest and largest accessible GWAS thyroid cancer data at the summary level. We performed four MR analyses, including the inverse-variance-weighted (IVW), weighted median, MR-Egger regression, and weighted mode, to evaluate the potential causal connection between genetically predicted breast cancer and higher risk for thyroid cancer. Sensitivity analysis, heterogeneity and pleiotropy tests were used to ensure the reliability of our findings.Results: Our study revealed causal relationship between genetically predicted breast cancer and thyroid cancer (IVW method, odds ratio (OR) = 1.135, 95% confidence interval (CI): 1.006 to 1.279, P = 0.038). However, there was no causal association between genetically predicted triple-negative breast cancer and thyroid cancer (OR = 0.817, 95% CI: 0.610 to 1.095, P = 0.177). There was no directional pleiotropy or horizontal pleiotropy in the present study.Conclusion: This two-sample MR study supports a causal link between ER-positive breast cancer and heightened the risk of thyroid cancer. Our analysis did not reveal a direct correlation between triple-negative breast cancer and thyroid cancer.

12 October 2018 in Oncology Reports
Verified
Journal Article
Closed access
PDF file
FHFeifei Huang
Feifei Huang
YWYanyang Wu
Yanyang Wu
HTHong Tan
Hong Tan
TGTianyao Guo
Tianyao Guo
KZKe Zhang
Ke Zhang
ZTZhongyi Tong
Zhongyi Tong
Non-small cell lung cancer (NSCLC) is one of the mostly deadly malignancies in the world. Nucleolin is a multifunctional protein that mainly regulates ribosome biogenesis but also has other functions including modulating the transcription of mRNAs and repressing RNA polymerase II. Nucleolin is overexpressed in various cancer cells, including NSCLC cells. It can confer resistance to apoptosis and promote cell migration and blood vessel formation by directly taking part in various tumor signal transduction pathways. The activities of nucleolin are regulated mainly by intracellular localization and post-translational modifications, including phosphorylation, glycosylation, methylation, and ADP-ribosylation. Phosphorylation of nucleolin (P-nucleolin) in NSCLC cells is still not well characterized. In the present study, the levels of nucleolin and P-nucleolin were examined in lung tissue and cells and it was demonstrated that levels of the two forms of nucleolin were significantly increased in NSCLC compared with non-cancerous tissues and cells. In addition, it was demonstrated that high expression levels of nucleolin and P-nucleolin were significantly associated with poor overall survival of NSCLC patients. Doxorubicin (DOX) is a type of anthracycline that has been used in the treatment of various types of cancer, including NSCLC. Upregulation of nucleolin through exogenous expression of nucleolin promoted A549 cell proliferation and migration, while downregulation of nucleolin through expression of small interfering RNA-nucleolin attenuated A549 cell proliferation and migration. Following stimulation with DOX, A549 cell proliferation and migration decreased and the expression of P-nucleolin also decreased. In order to investigate whether P-nucleolin is indispensable to the proliferation and migration of NSCLC cells, a plasmid encoding mutant nucleolin, in which the phosphorylation site at threonine-76 was mutated to alanine, was constructed. Compared with the A549 cells transfected with wild-type nucleolin, P-nucleolin expression and cell proliferation and migration were significantly decreased in A549 cells transfected with mutant nucleolin. These results indicate that targeting P-nucleolin may be a promising strategy for treating NSCLC patients.

28 October 2018 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
WYWu Yanyang
Wu Yanyang
YHYongquan Hu
Yongquan Hu
YYYuju Yuan
Yuju Yuan
YLYushuang Luo
Yushuang Luo
DLDengni Lai
Dengni Lai
DLDongbo Liu
Dongbo Liu

7 September 2018 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
ZTZhongyi Tong
Zhongyi Tong
YTYuting Tang
Yuting Tang
BJBimei Jiang
Bimei Jiang
YWYanyang Wu
Yanyang Wu
YLYanjuan Liu
Yanjuan Liu
XXXianzhong Xiao
Xianzhong Xiao

14 February 2023 in Microbiology Spectrum
Verified
Journal Article
Open access
HTHong Tan
Hong Tan
FHFeifei Huang
Feifei Huang
MHMeiyuan Huang
Meiyuan Huang
XWXia Wu
Xia Wu
ZTZhongyi Tong
Zhongyi Tong
HSF1 plays an important protective role in endotoxemic mice. However, the protective mechanisms of HSF1 are poorly understood.

26 September 2024 in Oncology Letters
Verified
Journal Article
Open access
PDF file
JLJunmi Lu
Junmi Lu
HTHong Tan
Hong Tan
TGTao Guo
Tao Guo
XCXi Chen
Xi Chen
ZTZhongyi Tong
Zhongyi Tong
The relationship between BRAF‑V600E mutations, mitochondrial DNA amplification and microsatellite instability‑high (MSI‑H) in colorectal cancer (CRC) has yet to be fully elucidated. The aim of the present study was to assess the association between the MSI status and BRAF‑V600E gene mutations/clinicopathological features/mitochondrial DNA amplification in CRC. A non‑interventional study analysis was performed using the clinicopathological features of 455 patients with CRC. Immunohistochemistry was used to evaluate four mismatch repair proteins (MutS homolog 2, MutS homolog 6, MutL homolog 1 and postmeiotic segregation increased 2), Ki‑67 index, and programmed cell death protein 1 (PD‑1) and programmed cell death‑ligand 1 (PD‑L1) expression. Additionally, PCR coupled with capillary electrophoresis were used to ascertain the MSI status. Moreover, amplification refractory mutation system‑PCR was used to detect BRAF‑V600E gene mutation and fluorescence in situ hybridization analysis was used to assess mitochondrial DNA. A total of 455 patients were divided into the MSI high (MSI‑H) group (n=52) and microsatellite stability (MSS) group (n=403) based on their MSI status. Compared with the results of immunohistochemistry of four mismatch repair proteins, the consistency rate between mismatch repair protein deficiency and MSI was 94.23%. There were significant differences in PD‑L1, primary tumor site, clinical stage, degree of differentiation, tumor size, lymph node metastasis and the occurrence of multiple primary tumors between the MSI‑H group and MSS group (P<0.05 or P<0.001). However, there were no significant differences for sex, age, PD‑1, Ki‑67 expression and BRAF‑V600E. The 24‑60‑month survival rate of the patients in the MSI‑H group was significantly higher than that of those in the MSS group (P<0.05). Furthermore, the number of mitochondrial DNA was significantly amplified in the MSI‑H group. In conclusion, the present study demonstrated thatthecombined detection of PD‑L1 and MSI in patients with CRC can provide more accurate and effective guidance for personalized treatment.